Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Jameson

Showing results (191-200 of 205) with videos related to

Pageof 21
Sort By:
The Oncologist|January 23, 2025
Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreductionVincent Chung, Angela Alistar, Carlos Becerra, et al.
Scandinavian Journal of Haematology|August 1, 1975
L-asparaginase and prednisolone pretreatment followed by rubidomycin and cytosine arabinoside for induction of remission in adult patients with acute myeloblastic leukaemiaA M Udén, G Brenning, L Engstedt, et al.
JAMA Oncology|October 4, 2019
Response Rate Following Albumin-Bound Paclitaxel Plus Gemcitabine Plus Cisplatin Treatment Among Patients With Advanced Pancreatic Cancer: A Phase 1b/2 Pilot Clinical TrialGayle S Jameson, Erkut Borazanci, Hani M Babiker, et al.
Redox Biology|November 6, 2025
Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancerGayle S Jameson, S Danielle LeGrand, Michael S Gordon, et al.
Journal of Affective Disorders|June 16, 2000
Evaluating the parent-of-origin effect in bipolar affective disorder. Is a more penetrant subtype transmitted paternally?J R Kornberg, J L Brown, A D Sadovnick, et al.
Circulation Research|July 14, 2023
Loss of the Atrial Fibrillation-Related Gene, <i>Zfhx3</i>, Results in Atrial Dilation and ArrhythmiasHeather S Jameson, Alan Hanley, Matthew C Hill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2012
A multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumorsGayle S Jameson, John T Hamm, Glen J Weiss, et al.
Breast Cancer Research and Treatment|September 12, 2014
A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancerGayle S Jameson, Emanuel F Petricoin, Jasgit Sachdev, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1979
Treatment of acute nonlymphoblastic leukemia in adults with daunorubicin-DNA complex: a preliminary reportG Gahrton, M Björkholm, G Brenning, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2018
Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trialLi-Tzong Chen, Jens T Siveke, Andrea Wang-Gillam, et al.
Pageof 21

Showing results (191-200 of 205) with videos related to

Sort By:
Pageof 21
The Oncologist|January 23, 2025
Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreductionVincent Chung, Angela Alistar, Carlos Becerra, et al.
Scandinavian Journal of Haematology|August 1, 1975
L-asparaginase and prednisolone pretreatment followed by rubidomycin and cytosine arabinoside for induction of remission in adult patients with acute myeloblastic leukaemiaA M Udén, G Brenning, L Engstedt, et al.
JAMA Oncology|October 4, 2019
Response Rate Following Albumin-Bound Paclitaxel Plus Gemcitabine Plus Cisplatin Treatment Among Patients With Advanced Pancreatic Cancer: A Phase 1b/2 Pilot Clinical TrialGayle S Jameson, Erkut Borazanci, Hani M Babiker, et al.
Redox Biology|November 6, 2025
Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancerGayle S Jameson, S Danielle LeGrand, Michael S Gordon, et al.
Journal of Affective Disorders|June 16, 2000
Evaluating the parent-of-origin effect in bipolar affective disorder. Is a more penetrant subtype transmitted paternally?J R Kornberg, J L Brown, A D Sadovnick, et al.
Circulation Research|July 14, 2023
Loss of the Atrial Fibrillation-Related Gene, <i>Zfhx3</i>, Results in Atrial Dilation and ArrhythmiasHeather S Jameson, Alan Hanley, Matthew C Hill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2012
A multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumorsGayle S Jameson, John T Hamm, Glen J Weiss, et al.
Breast Cancer Research and Treatment|September 12, 2014
A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancerGayle S Jameson, Emanuel F Petricoin, Jasgit Sachdev, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1979
Treatment of acute nonlymphoblastic leukemia in adults with daunorubicin-DNA complex: a preliminary reportG Gahrton, M Björkholm, G Brenning, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2018
Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trialLi-Tzong Chen, Jens T Siveke, Andrea Wang-Gillam, et al.
Pageof 21